We are live on ! Find out more
CBIO

Crescent Biopharma
CBIO

48 hedge funds and large institutions have $131M invested in Crescent Biopharma in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

2% less capital invested

Capital invested by funds: $135M → $131M (-$3.14M)

4% less funds holding

Funds holding: 50 → 48 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
5
Increased
15
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$402K
2
BFA
BlackRock Fund Advisors
California
+$396K
3
State Street
State Street
Massachusetts
+$213K
4
Renaissance Technologies
Renaissance Technologies
New York
+$149K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$126K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$639K
2
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$400K
3
DCM
DAFNA Capital Management
California
-$204K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$190K
5
Deutsche Bank
Deutsche Bank
Germany
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
51
DAFNA Capital Management
California
– -$204K -280 Closed
TC
52
TFS Capital
Pennsylvania
– -$149K -204 Closed
SIM
53
Spark Investment Management
New York
– -$82K -114 Closed
PAM
54
Panagora Asset Management
Massachusetts
– -$59K -81 Closed
Walleye Trading
55
Walleye Trading
New York
– -$34K -47 Closed
1 2
3